MAR 14, 2022
Ocular Pathology/Oncology, Oculoplastics/Orbit
Dr. Hakan Demirci discusses his study of PD-1 cell death inhibitors as an effective immunotherapy for treating locally unresectable advanced conjunctival squamous cell carcinoma with orbital extensions. Ideal patients include those with high tumor burden. The treatment offers a globe-sparing alternative to exenteration.
Relevant Financial Disclosures: None